Lipoxin compounds and their use in treating cell proliferative disorders
OwnerCharles Serhaninventor
Life of this patent
Estimating the term…
Abstract
Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.
Claims4
A method for treating a subject for restenosis comprising administering to said subject a composition comprising an effective amount of a lipoxin A4 compound and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, such that restenosis is prevented, reduced, or inhibited.
The method of claim 2, wherein the lipoxin A4 compound is LXA4 or 15-R/S-methyl, LXA4.
A method for treating a subject for restenosis comprising administering to said subject a composition comprising an effective amount of a 15-epi-lipoxin A4 compound and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, such that restenosis is prevented, reduced, or inhibited.
Dependencies are inferred from the claim text.